News Sentiment

VRXA sentiment intelligence

Veraxa Biotech AG Ordinary Shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 40 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.20 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 32

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+7.8% over one week, -89.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Why VERAXA Biotech (VRXA) Could Benefit More Than Others From AI's Growing Impact on Drug R&D

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 7.8% Price confirming higher
Trend fit Trend inactive -89.0% over four weeks
Fair value -64.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 2
Neutral 37
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 32
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
NewMediaWire 5
Stock Titan 5
GlobeNewswire 3
TradingView 3
Barchart.com 2
The Globe and Mail 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 9
Deals and strategy 3
Analyst action 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 40